Comments on: `Til Death Do Us Part, But First, the Pre-Nup: Why CAPA Needs to Evolve http://www.biotechblog.com/2007/07/19/til-death-do-us-part-but-first-the-pre-nup-why-capa-needs-to-evolve/ Commercial, legal, political, and scientific trends in biotechnology Thu, 09 Feb 2012 15:32:22 +0000 hourly 1 http://wordpress.org/?v=3.3 By: Paul Sandschneider http://www.biotechblog.com/2007/07/19/til-death-do-us-part-but-first-the-pre-nup-why-capa-needs-to-evolve/comment-page-1/#comment-4614 Paul Sandschneider Wed, 25 Jul 2007 22:25:11 +0000 http://www.biotechblog.com/2007/07/19/til-death-do-us-part-but-first-the-pre-nup-why-capa-needs-to-evolve/#comment-4614 Realy, realy nice work! I was impressed! My own are Realy, realy nice work! I was impressed! My own are

]]> By: Agnes Shanley http://www.biotechblog.com/2007/07/19/til-death-do-us-part-but-first-the-pre-nup-why-capa-needs-to-evolve/comment-page-1/#comment-4611 Agnes Shanley Wed, 25 Jul 2007 19:06:57 +0000 http://www.biotechblog.com/2007/07/19/til-death-do-us-part-but-first-the-pre-nup-why-capa-needs-to-evolve/#comment-4611 You've just made our day. Thank you for the kind words. We'd like to expand our coverage of biopharma and pharma outside of the U.S. If you or any colleagues ever feel the urge to write (technical articles or opinion pieces), please let me know. Sincerely, Agnes Shanley, Editor ashanley@putman.net You’ve just made our day. Thank you for the kind words.

We’d like to expand our coverage of biopharma and pharma outside of the U.S. If you or any colleagues ever feel the urge to write (technical articles or opinion pieces), please let me know.

Sincerely,
Agnes Shanley, Editor
ashanley@putman.net

]]> By: Natalie Netherlands http://www.biotechblog.com/2007/07/19/til-death-do-us-part-but-first-the-pre-nup-why-capa-needs-to-evolve/comment-page-1/#comment-4609 Natalie Netherlands Wed, 25 Jul 2007 18:40:07 +0000 http://www.biotechblog.com/2007/07/19/til-death-do-us-part-but-first-the-pre-nup-why-capa-needs-to-evolve/#comment-4609 You have an outstanding good and well structured site. I enjoyed browsing through it. You have an outstanding good and well structured site. I enjoyed browsing through it.

]]> By: PharmaManufacturing http://www.biotechblog.com/2007/07/19/til-death-do-us-part-but-first-the-pre-nup-why-capa-needs-to-evolve/comment-page-1/#comment-4560 PharmaManufacturing Fri, 20 Jul 2007 19:06:52 +0000 http://www.biotechblog.com/2007/07/19/til-death-do-us-part-but-first-the-pre-nup-why-capa-needs-to-evolve/#comment-4560 Dear Dr. Singh, I am always happy to chat with a fellow scientist. I looked at the webpage indicated and there was limited information as to the exact work being performed. If you could enlighten me as to the nature of his work, I would love to discuss it. As far as the results of this work, it matters not to domestic pharmaceutical companies, if the product is researched, produced, and imported from abroad. The patients will receive benefit, as will any stockholders in the company, by my thrust in my articles is towards US and other national companies to improve their manufacturing sites. (Multinationals can always seek cheaper hands for the labor.) As far as the R&D, as a mortal, prone to diseases, I always applaud any advance in science. However, as an observer of human nature, I mourn for the thousands of scientists who will be replaced by outsourced work to lower paying areas. I count myself among them, but am fortunate to have a specialty that is still in demand (Near-Infrared Spectroscopy.) I look forward to hearing from you. Sincerely, Emil Emil W. Ciurczak (email) emil@ciurczak.com Dear Dr. Singh,

I am always happy to chat with a fellow scientist. I looked at the webpage indicated and there was limited information as to the exact work being performed. If you could enlighten me as to the nature of his work, I would love to discuss it.

As far as the results of this work, it matters not to domestic pharmaceutical companies, if the product is researched, produced, and imported from abroad. The patients will receive benefit, as will any stockholders in the company, by my thrust in my articles is towards US and other national companies to improve their manufacturing sites. (Multinationals can always seek cheaper hands for the labor.) As far as the R&D, as a mortal, prone to diseases, I always applaud any advance in science.

However, as an observer of human nature, I mourn for the thousands of scientists who will be replaced by outsourced work to lower paying areas. I count myself among them, but am fortunate to have a specialty that is still in demand (Near-Infrared Spectroscopy.)

I look forward to hearing from you.

Sincerely,

Emil
Emil W. Ciurczak
(email) emil@ciurczak.com

]]> By: Rama Singh, MD, Ph.D, Sc.D http://www.biotechblog.com/2007/07/19/til-death-do-us-part-but-first-the-pre-nup-why-capa-needs-to-evolve/comment-page-1/#comment-4559 Rama Singh, MD, Ph.D, Sc.D Fri, 20 Jul 2007 17:05:49 +0000 http://www.biotechblog.com/2007/07/19/til-death-do-us-part-but-first-the-pre-nup-why-capa-needs-to-evolve/#comment-4559 What do you think about the research that David Sinclair (of Harvard Med and Sirtris Pharma) is doing on sirtuins?(http://www.sirtrispharma.com) Will his work be as world-changing as some people speculate? The recent report on ABC's Nightline was intriguing. What do you think about the research that David Sinclair (of Harvard Med and Sirtris Pharma) is doing on sirtuins?(http://www.sirtrispharma.com) Will his work be as world-changing as some people speculate? The recent report on ABC’s Nightline was intriguing.

]]>